These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23777205)

  • 21. Clusterin induces the secretion of TNF-α and the chemotactic migration of macrophages.
    Shim YJ; Kang BH; Choi BK; Park IS; Min BH
    Biochem Biophys Res Commun; 2012 May; 422(1):200-5. PubMed ID: 22575505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of peritoneal and systemic neutrophil-derived tumor necrosis factor-alpha release in patients with severe peritonitis: role of tumor necrosis factor-alpha converting enzyme cleavage.
    Kermarrec N; Selloum S; Plantefeve G; Chosidow D; Paoletti X; Lopez A; Mantz J; Desmonts JM; Gougerot-Pocidalo MA; Chollet-Martin S
    Crit Care Med; 2005 Jun; 33(6):1359-64. PubMed ID: 15942356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha production.
    Renier G; Clément I; Desfaits AC; Lambert A
    Endocrinology; 1996 Nov; 137(11):4611-8. PubMed ID: 8895324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-alpha-converting enzyme (TACE)/ADAM-17.
    Fabre-Lafay S; Garrido-Urbani S; Reymond N; Gonçalves A; Dubreuil P; Lopez M
    J Biol Chem; 2005 May; 280(20):19543-50. PubMed ID: 15784625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma.
    Leek RD; Landers R; Fox SB; Ng F; Harris AL; Lewis CE
    Br J Cancer; 1998 Jun; 77(12):2246-51. PubMed ID: 9649140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of TNF-alpha-converting enzyme-ectodomain shedding by pathogenic autoantibodies.
    Sisto M; Lisi S; Lofrumento DD; Frassanito MA; Cucci L; D'Amore S; Mitolo V; D'Amore M
    Int Immunol; 2009 Dec; 21(12):1341-9. PubMed ID: 19854762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endotoxin recognition in fish results in inflammatory cytokine secretion not gene expression.
    Roher N; Callol A; Planas JV; Goetz FW; MacKenzie SA
    Innate Immun; 2011 Feb; 17(1):16-28. PubMed ID: 20083499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TACE inhibition amplifies TNF-alpha-mediated colonic epithelial barrier disruption.
    Fréour T; Jarry A; Bach-Ngohou K; Dejoie T; Bou-Hanna C; Denis MG; Mosnier JF; Laboisse CL; Masson D
    Int J Mol Med; 2009 Jan; 23(1):41-8. PubMed ID: 19082505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-10 regulates TNF-alpha-converting enzyme (TACE/ADAM-17) involving a TIMP-3 dependent and independent mechanism.
    Brennan FM; Green P; Amjadi P; Robertshaw HJ; Alvarez-Iglesias M; Takata M
    Eur J Immunol; 2008 Apr; 38(4):1106-17. PubMed ID: 18383040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stroke-induced subventricular zone proliferation is promoted by tumor necrosis factor-alpha-converting enzyme protease activity.
    Katakowski M; Chen J; Zhang ZG; Santra M; Wang Y; Chopp M
    J Cereb Blood Flow Metab; 2007 Apr; 27(4):669-78. PubMed ID: 16926839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-cell interaction promotes rat marrow stromal cell differentiation into endothelial cell via activation of TACE/TNF-alpha signaling.
    Xu J; Liu X; Chen J; Zacharek A; Cui X; Savant-Bhonsale S; Chopp M; Liu Z
    Cell Transplant; 2010; 19(1):43-53. PubMed ID: 19796498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.
    Zhang Y; Xu J; Levin J; Hegen M; Li G; Robertshaw H; Brennan F; Cummons T; Clarke D; Vansell N; Nickerson-Nutter C; Barone D; Mohler K; Black R; Skotnicki J; Gibbons J; Feldmann M; Frost P; Larsen G; Lin LL
    J Pharmacol Exp Ther; 2004 Apr; 309(1):348-55. PubMed ID: 14718605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble tumor necrosis factor (TNF) receptor-1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor-beta1.
    Waetzig GH; Rosenstiel P; Arlt A; Till A; Bräutigam K; Schäfer H; Rose-John S; Seegert D; Schreiber S
    FASEB J; 2005 Jan; 19(1):91-3. PubMed ID: 15514103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TACE/ADAM17-TNF-alpha pathway in rat cortical cultures after exposure to oxygen-glucose deprivation or glutamate.
    Hurtado O; Lizasoain I; Fernández-Tomé P; Alvarez-Barrientos A; Leza JC; Lorenzo P; Moro MA
    J Cereb Blood Flow Metab; 2002 May; 22(5):576-85. PubMed ID: 11973430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of ADAM17 in the ectodomain shedding of TNF-alpha and its receptors by neutrophils and macrophages.
    Bell JH; Herrera AH; Li Y; Walcheck B
    J Leukoc Biol; 2007 Jul; 82(1):173-6. PubMed ID: 17510296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in a model of intestinal reperfusion injury in mice.
    Souza DG; Ferreira FL; Fagundes CT; Amaral FA; Vieira AT; Lisboa RA; Andrade MV; Trifilieff A; Teixeira MM
    Eur J Pharmacol; 2007 Sep; 571(1):72-80. PubMed ID: 17619015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate.
    Zhang Z; Oliver P; Lancaster JR; Schwarzenberger PO; Joshi MS; Cork J; Kolls JK
    FASEB J; 2001 Feb; 15(2):303-5. PubMed ID: 11156944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).
    Rabinowitz MH; Andrews RC; Becherer JD; Bickett DM; Bubacz DG; Conway JG; Cowan DJ; Gaul M; Glennon K; Lambert MH; Leesnitzer MA; McDougald DL; Moss ML; Musso DL; Rizzolio MC
    J Med Chem; 2001 Nov; 44(24):4252-67. PubMed ID: 11708926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor-α converting enzyme is a key mediator of abdominal aortic aneurysm development.
    Kaneko H; Anzai T; Horiuchi K; Kohno T; Nagai T; Anzai A; Takahashi T; Sasaki A; Shimoda M; Maekawa Y; Shimizu H; Yoshikawa T; Okada Y; Yozu R; Fukuda K
    Atherosclerosis; 2011 Oct; 218(2):470-8. PubMed ID: 21722904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor necrosis factor-alpha stimulates fractalkine production by mesangial cells and regulates monocyte transmigration: down-regulation by cAMP.
    Chen YM; Lin SL; Chen CW; Chiang WC; Tsai TJ; Hsieh BS
    Kidney Int; 2003 Feb; 63(2):474-86. PubMed ID: 12631113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.